CA2957430C - Composition immunogene dirigee contre campylobacter jejuni - Google Patents

Composition immunogene dirigee contre campylobacter jejuni Download PDF

Info

Publication number
CA2957430C
CA2957430C CA2957430A CA2957430A CA2957430C CA 2957430 C CA2957430 C CA 2957430C CA 2957430 A CA2957430 A CA 2957430A CA 2957430 A CA2957430 A CA 2957430A CA 2957430 C CA2957430 C CA 2957430C
Authority
CA
Canada
Prior art keywords
ido
polysaccharide
hep
immunogenic composition
jejuni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2957430A
Other languages
English (en)
Other versions
CA2957430A1 (fr
Inventor
Patricia Guerry
Mario Artur Monteiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Navy
Original Assignee
US Department of Navy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/733,114 external-priority patent/US9999591B2/en
Application filed by US Department of Navy filed Critical US Department of Navy
Publication of CA2957430A1 publication Critical patent/CA2957430A1/fr
Application granted granted Critical
Publication of CA2957430C publication Critical patent/CA2957430C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition immunogène dirigée contre Campylobacter jejuni comprenant un polysaccharide isolé de capsule provenant de souches pathogènes sélectionnées de Campylobacter jejuni. L'invention concerne également des méthodes d'utilisation desdites compositions de polysaccharide dans l'induction d'une réponse immunitaire anti-C. jejuni.
CA2957430A 2014-08-07 2015-07-31 Composition immunogene dirigee contre campylobacter jejuni Active CA2957430C (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201462034436P 2014-08-07 2014-08-07
US62/034,436 2014-08-07
US201462054454P 2014-09-24 2014-09-24
US62/054,454 2014-09-24
US201562127927P 2015-03-04 2015-03-04
US62/127,927 2015-03-04
US201562165301P 2015-05-22 2015-05-22
US62/165,301 2015-05-22
US14/733,114 US9999591B2 (en) 2005-09-21 2015-06-08 Immunogenic composition against Campylobacter jejuni
US14/733,114 2015-06-08
PCT/US2015/043070 WO2016022412A1 (fr) 2014-08-07 2015-07-31 Composition immunogène dirigée contre campylobacter jejuni

Publications (2)

Publication Number Publication Date
CA2957430A1 CA2957430A1 (fr) 2016-02-11
CA2957430C true CA2957430C (fr) 2021-01-12

Family

ID=55264367

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2957430A Active CA2957430C (fr) 2014-08-07 2015-07-31 Composition immunogene dirigee contre campylobacter jejuni

Country Status (5)

Country Link
EP (1) EP3188748A4 (fr)
JP (1) JP6530051B2 (fr)
AU (2) AU2015301368B2 (fr)
CA (1) CA2957430C (fr)
WO (1) WO2016022412A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5557415B2 (ja) * 2003-06-02 2014-07-23 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 吸着させたトキソイドおよび多糖類含有抗原を含む微粒子に基づく免疫原性組成物
JP5044754B2 (ja) * 2005-09-21 2012-10-10 アメリカ合衆国 カンピロバクター・ジェジュニに対するワクチン成分として使用される免疫原莢膜組成物
CA2694495C (fr) * 2007-07-27 2013-05-14 The United States Of America As Represented By The Secretary Of The Navy Composition de capsule pour une utilisation en tant qu'immunogene contre campylobacter jejuni
US9308246B2 (en) * 2010-05-28 2016-04-12 The United States Of America As Represented By The Secretary Of The Navy Capsule composition for use as immunogen against Campylobacter jejuni
CA2961883C (fr) * 2014-09-24 2023-10-03 The United States Of America As Represented By The Secretary Of The Navy Construction recombinee combinant les bacteries escherichia coli enterotoxinogene et campylobacter jejuni

Also Published As

Publication number Publication date
AU2015301368A1 (en) 2017-02-09
AU2015301368B2 (en) 2018-04-05
AU2018204255B2 (en) 2019-04-18
WO2016022412A9 (fr) 2016-05-12
EP3188748A1 (fr) 2017-07-12
CA2957430A1 (fr) 2016-02-11
JP2017524710A (ja) 2017-08-31
WO2016022412A1 (fr) 2016-02-11
WO2016022412A8 (fr) 2017-04-20
JP6530051B2 (ja) 2019-06-12
EP3188748A4 (fr) 2018-04-18
AU2018204255A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
US10765627B2 (en) Immunogenic composition against Campylobacter jejuni
US9308246B2 (en) Capsule composition for use as immunogen against Campylobacter jejuni
Kubler-Kielb et al. O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a
US10500262B2 (en) Synthetic antigen constructs against Campylobacter jejuni
JP6030282B2 (ja) カンピロバクター・ジェジュニに対する免疫原として使用するための莢膜組成物
CA2957430C (fr) Composition immunogene dirigee contre campylobacter jejuni
CA2565247C (fr) Epitopes de lipopolysaccharides a noyau interne conserve utilises comme candidats de vaccins a especes multiples
EP3003362A1 (fr) Antigène bactérien immunogène isolé et son utilisation pour la prévention et le traitement d'infections causées par des bactéries à gram négatif
WO2002016440A2 (fr) Epitopes d'oligosaccharide a noyau interne de lipopolysaccharide d'haemophilus influenzae utilises comme vaccins pour prevenir les infections a haemophilus influenzae
US10500261B2 (en) Synthetic antigen constructs against campylobacter jejuni
DePass Campylobacter jejuni Serotype HS: 10 Capsular Polysaccharide and the Conjugate Vaccine thereof
Omari Synthesis of Campylobacter and Shigella glycoconjugate Vaccines

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170206